Molecular imaging as a tool for personalized and targeted anticancer therapy

Cancer is not a single disease, but rather, a collection of diseases in individuals that are well recognized to vary significantly in their molecular biology, clinical presentation, and outcome.(1) In this context, there can be no better argument for personalized treatment strategies. Molecular imaging is a new and powerful tool that which can aid the oncologist in noninvasively assessing the phenotypic signature of a tumor in an individual patient and thus, in making these therapeutic decisions.(2)